ETG Lublin Sp. z o.o.
- Address
- lock Available on a paid plan
Cardiovascular Diseases and Hypertension Research
At ETG Lublin Sp. z o.o., clinical research in cardiovascular medicine focuses on people with established cardiovascular disease, high cardiovascular risk, and hypertension. The trials are designed to explore whether new approaches can better prevent serious heart and circulation-related events and improve disease control.
- Evaluating ways to reduce the risk of heart attack, stroke, and cardiovascular death
- Studying treatment options for blood pressure management in higher-risk patients
- Testing new therapies aimed at lowering long-term cardiovascular event risk
This area reflects a strong interest in prevention-focused research, with the site contributing to studies that aim to improve outcomes for patients at risk of major cardiovascular disease complications.
Skin and Connective Tissue Diseases Research
Clinical trials in skin and connective tissue diseases at this site center on venous leg ulcer care. The main goal is to assess whether new wound treatments can support cleaner wound beds, improve debridement, and help advance healing in people living with chronic ulcers.
- Investigating treatment strategies for venous leg ulcers
- Assessing wound debridement and preparation of the wound bed
- Comparing a new wound therapy with placebo to understand effectiveness and safety
This work adds an important wound-care dimension to the research portfolio at ETG Lublin Sp. z o.o., linking practical healing outcomes with broader dermatology and tissue repair research.
Site Overview
Activity Indicator
Last 6 months
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Amgen Inc.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in ETG Lublin Sp. z o.o.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Olpasiran in Reducing First Major Cardiovascular Events in Patients with Elevated Lipoprotein(a) Levels: A Double-Blind, Randomized, Placebo-Controlled Study | Amgen Inc. | Phase III | Not Yet Recruiting | — | — |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.